POS-045 EARLY RENAL REPLACEMENT THERAPY MAY REDUCE THE ALL-CAUSE MORTALITY OF SEVERE COVID-19

J Qian,M Wang,H You,J Luo,S Li,S Chen,Y Chen,X Li,K Wang,W.Z Zhang,L Yuan,L Ni,J Chen

doi:10.1016/j.ekir.2021.03.051

POS-045 EARLY RENAL REPLACEMENT THERAPY MAY REDUCE THE ALL-CAUSE MORTALITY OF SEVERE COVID-19

J Qian, M Wang + Show 11 more

Open Access

https://doi.org/10.1016/j.ekir.2021.03.051

Copy DOI

Journal: Kidney International Reports	Publication Date: Apr 1, 2021
License type: cc-by-nc-nd

Affiliation: Huashan Hospital, Fudan University

#Efficacy Of Renal Replacement Therapy #ICU Adults + Show 7 more

Abstract
Full-Text PDF
Similar Papers

Abstract

The efficacy of renal replacement therapy (RRT) remains to be validated in COVID-19. In this respective cohort study, we aimed to assess the efficacy of early initiation of RRT in ICU adults with severe COVID-19.

Full Text

Paper version not known

Open DOI Link

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: Kidney International Reports

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.